Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Dlbcl-Chop'
Dlbcl-Chop published presentations and documents on DocSlides.
Novel genetic subgroups inform on shared pathobiology within adult and pediatric Burkitt lymphoma
by madison
Nicole Thomas. Morin Lab. SFU. Burnaby, BC, Canada...
Treatment Of Later Relapse/ Chemo-Resistant
by ida
Diffuse Large B Cell Lymphoma. Foroud. . shahbazi...
1 DLBCL of the elderly in age older than life expectancy
by tabitha
the single institute experience in Taiwan . Sheng...
Precision Medicine For Aggressive Lymphoma
by susan
(PMAL) Consortium and Associated Trials. 2016. CON...
How To Get Lymphoma Patients To CAR-T Therapy In The UK
by vivian
Dr. Sanne Lugthart. (. Dr. Stephen Robinson). Un...
Journal section Oral Medicine and Pathology Publication Types Case
by berey
Souto GR, Pereira TSF, Castro AF, Mesquita RA. Dif...
MYC/BCL2 protein coexpression
by Ziggystardust
contributes inferior outcome in DLBCL . ...
Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma
by isabella2
Dr. Gilles SALLES. Chief . of. . the. . Lymphoma...
Changes in Life Expectation for Diffuse Large
by roberts
B-Cell . Lymphoma (DLBCL) Patients, . 1983 . – 2...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Updates in Diffuse Large B-Cell Lymphoma
by sherrill-nordquist
Program Goals. DLBCL Subtypes . 2008 WHO Classifi...
Jeremy Abramson, MD Director, Lymphoma Program
by natalie
Jon and Jo Ann Hagler Chair in Lymphoma. Massachus...
CAR T Cells in non-Hodgkin lymphoma (NHL)
by elena
Jean Koff, MD, MSc. July 20, 2023. disclosures. Re...
HIGH GRADE B
by luna
- CELL LYMPHOMA DAVID NOLTE, MD (PGY - 2) HUSSAM...
Understanding Lymphoma Series
by jones
Helpline: 800 500 9976 | helpline@lymphoma.org U...
Understanding Lymphoma Series
by evans
Helpline: 800 500 9976 | helpline@lymphoma.org U...
MALT GASTRIC LYMPHOMA
by adia
1 AN UPDATE OF PATHOGENETIC FEATURES WCRJ 2016; 3 ...
NON-HODGKINS LYMPHOMA DR. SANJANA BHAGWAT
by DreamGirl
MODERATOR : DR. GANAPULE . Definition . Lymphomas ...
ESMO-Recommendations-Covid-19-DLBCL-MCL-ATCL-Slide-Set
by bitsy
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
by susan
Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison...
CAR-T Therapy in non-Hodgkin lymphomas
by natalie
Jonathon B. Cohen, MD. Dept of . Hematology. /Medi...
MYC-associated and Double Hit
by myesha-ticknor
L. ymphomas. Lisa G Roth, MD. Division of Hematol...
Load More...